Vanguard Personalized Indexing Management’s Telix Pharmaceuticals TLX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TLX Stock Details TLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$680K	Buy	58,989 +25,736	+77%	+$262K	0.01%	1214
2026 Q1	$318K	Buy	33,253 +15,112	+83%	+$115K	﹤0.01%	1576
2025 Q4	$136K	Sell	18,141 -237	-1%	-$2.28K	﹤0.01%	1780
2025 Q3	$176K	Sell	18,378 -97	-0.5%	-$1.19K	﹤0.01%	1732
2025 Q2	$297K	Buy	+18,475	New	+$310K	﹤0.01%	1448

Other funds holding TLX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

PIC

Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Vanguard Personalized Indexing Management's TLX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Telix Pharmaceuticals (TLX) stake by 77% in Q2 2026, buying an estimated $262K and bringing the position to 58,989 shares worth $680K. The position accounts for 0.01% of the portfolio, ranked #1214.

Vanguard Personalized Indexing Management first reported a position in TLX in Q2 2025 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

Vanguard Personalized Indexing Management held 58,989 shares of Telix Pharmaceuticals worth $680K as of Q2 2026.
Vanguard Personalized Indexing Management bought 25,736 Telix Pharmaceuticals shares in Q2 2026, an estimated $262K.
Telix Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1214 holding.
Vanguard Personalized Indexing Management first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
61 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.